Overview of the legal framework applicable to the marker method for the detection of human growth hormone

Growth Hormone and IGF Research

Volumn 19, Issue 4, 2009, Pages 366-368

  Young, Richard R ^a   Bielak, Jennifer S ^a   Horvitz, Sarah L ^a  

^a Colorado Springs Office of Holme Roberts and Owen LLP ^*  (United States)

Author keywords

Doping

Indexed keywords

ERYTHROPOIETIN; HUMAN GROWTH HORMONE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SOMATOMEDIN C; STANOZOLOL;

ARTICLE; ATHLETIC PERFORMANCE; BLOOD SAMPLING; CRIMINAL JUSTICE; DOPING; FALSE POSITIVE RESULT; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; LEGAL ASPECT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARDIZATION;

EID: 67651172758     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.04.025     Document Type: Article

References (11)

1. J.K. Powrie Detection of growth hormone abuse in sport Growth Hormone and IGF Research 17 2007 220 226
2. Hamilton v. USADA and UCI, CAS 2005/A/884.
3. Susin v. FINA, CAS 2000/A/274.
4. UCI v. Hamburger, CAS 2001/A/343.
5. UNESCO International Convention against Doping in Sport, Overview, .
6. UNESCO International Convention against Doping in Sport, Ratifications, .
7. The World Anti-Doping Code 2003, .
8. The World Anti-Doping Code 2009, .
9. The World Anti-Doping Code, International Standard, Laboratories, January 2009, .
10. The World Anti-Doping Code, International Standard, Testing, January 2009, .
11. The World Anti-Doping Code, the 2009 Prohibited List, International Standard, .